JP2021519600A5 - - Google Patents

Info

Publication number
JP2021519600A5
JP2021519600A5 JP2020554536A JP2020554536A JP2021519600A5 JP 2021519600 A5 JP2021519600 A5 JP 2021519600A5 JP 2020554536 A JP2020554536 A JP 2020554536A JP 2020554536 A JP2020554536 A JP 2020554536A JP 2021519600 A5 JP2021519600 A5 JP 2021519600A5
Authority
JP
Japan
Prior art keywords
influenza
ferritin
polypeptide
antigenic
polypeptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020554536A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519600A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025377 external-priority patent/WO2019195284A1/en
Publication of JP2021519600A publication Critical patent/JP2021519600A/ja
Publication of JP2021519600A5 publication Critical patent/JP2021519600A5/ja
Priority to JP2024006461A priority Critical patent/JP2024041980A/ja
Pending legal-status Critical Current

Links

JP2020554536A 2018-04-03 2019-04-02 抗原性インフルエンザ−フェリチンポリペプチド Pending JP2021519600A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024006461A JP2024041980A (ja) 2018-04-03 2024-01-19 抗原性インフルエンザ－フェリチンポリペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652204P 2018-04-03 2018-04-03
US62/652,204 2018-04-03
PCT/US2019/025377 WO2019195284A1 (en) 2018-04-03 2019-04-02 Antigenic influenza-ferritin polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024006461A Division JP2024041980A (ja) 2018-04-03 2024-01-19 抗原性インフルエンザ－フェリチンポリペプチド

Publications (2)

Publication Number Publication Date
JP2021519600A JP2021519600A (ja) 2021-08-12
JP2021519600A5 true JP2021519600A5 (https=) 2022-04-07

Family

ID=66175544

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020554536A Pending JP2021519600A (ja) 2018-04-03 2019-04-02 抗原性インフルエンザ−フェリチンポリペプチド
JP2024006461A Pending JP2024041980A (ja) 2018-04-03 2024-01-19 抗原性インフルエンザ－フェリチンポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024006461A Pending JP2024041980A (ja) 2018-04-03 2024-01-19 抗原性インフルエンザ－フェリチンポリペプチド

Country Status (4)

Country Link
EP (1) EP3773703A1 (https=)
JP (2) JP2021519600A (https=)
CN (1) CN112512565A (https=)
WO (1) WO2019195284A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3773698A1 (en) 2018-04-03 2021-02-17 Sanofi Ferritin proteins
WO2019195314A2 (en) 2018-04-03 2019-10-10 Sanofi Antigenic epstein barr virus polypeptides
JP7614841B2 (ja) 2018-04-03 2025-01-16 サノフイ 抗原性呼吸器合胞体ウイルスポリペプチド
EP4139331A4 (en) * 2020-04-22 2024-10-02 Aramis Biotechnologies Inc. SUPRASTRUCTURE WITH MODIFIED INFLUENZA HEMAGGLUTININ WITH REDUCED INTERACTION WITH SIALIC ACID
WO2021231729A1 (en) * 2020-05-13 2021-11-18 Sanofi Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
US20240165224A1 (en) * 2021-03-26 2024-05-23 Glaxosmithkline Biologicals Sa Immunogenic compositions

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
EP1167379A3 (en) 1994-07-15 2004-09-08 University Of Iowa Research Foundation Immunomodulatory oligonucleotides
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP1003531B1 (en) 1997-05-20 2007-08-22 Ottawa Health Research Institute Processes for preparing nucleic acid constructs
AU760549B2 (en) 1998-04-03 2003-05-15 University Of Iowa Research Foundation, The Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
WO2001075436A1 (en) 2000-04-03 2001-10-11 Board Of Trustees Of The Leland Stanford Junior University A method for protein structure alignment
US7774185B2 (en) 2004-09-14 2010-08-10 International Business Machines Corporation Protein structure alignment using cellular automata
EP2515112B1 (en) * 2011-04-22 2015-08-12 Sysmex Corporation Method for electrochemically detecting analyte
JP5795184B2 (ja) * 2011-04-22 2015-10-14 国立大学法人 奈良先端科学技術大学院大学 被検物質の電気化学的検出方法
US9580475B2 (en) 2011-06-20 2017-02-28 University of Pittsburgh—of the Commonwealth System of Higher Education Computationally optimized broadly reactive antigens for H1N1 influenza
EP2758038B1 (en) * 2011-09-23 2018-05-30 The United States of America, as represented by The Secretary, Department of Health & Human Services Novel influenza hemagglutinin protein-based vaccines
CA2868330A1 (en) 2012-03-30 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
EP2970398B1 (en) * 2013-03-13 2024-05-08 The United States of America, as Represented by The Secretary, Department of Health and Human Services Prefusion rsv f proteins and their use
US10363301B2 (en) * 2014-05-27 2019-07-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Stabilized influenza hemagglutinin stem region trimers and uses thereof
US9703095B2 (en) 2015-01-05 2017-07-11 Edward Pakhchyan Light modulator for MEMS display
BR112018076015A8 (pt) 2016-06-17 2022-06-28 Sanofi Pasteur Formulações imunogênicas compreendendo adjuvantes de polímero do ácido poliacrílico linear ou ramificado .

Similar Documents

Publication Publication Date Title
JP2021519600A5 (https=)
US11793871B2 (en) Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
AU2022279441A1 (en) Novel multivalent nanoparticle-based vaccines
Jegerlehner et al. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses
Laver et al. Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies
JP7298046B2 (ja) インフルエンザヘマグルチニンタンパク質およびその方法
Deliyannis et al. Induction of long-term memory CD8+ T cells for recall of viral clearing responses against influenza virus
Mardanova et al. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
JP2016199557A5 (https=)
JP2021519597A5 (https=)
CN107488218B (zh) 一种多肽、免疫原性偶联物和流感疫苗
JP2016534070A (ja) 安定化ワクチンの製造のための新規方法
JP2018504412A5 (https=)
WO2007011904A3 (en) Recombinant flu vaccines
EA202192921A1 (ru) Рекомбинантные антигены вируса гриппа
JP2019214579A5 (https=)
CN101227919B (zh) 基于肽的流感疫苗制剂
JP2010508030A5 (https=)
RU2019113989A (ru) Лекарственное средство
JP2018501258A5 (https=)
US10286062B2 (en) Universal influenza vaccine
US20180244724A1 (en) Polypeptide compound and preparation method and use thereof
JP2019534242A5 (https=)
Lim et al. RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform
CN107522777B (zh) 用于预防或治疗流感病毒的多肽、免疫原性偶联物及用途